The application of artificial intelligence for Rapid On-Site Evaluation during flexible bronchoscopy
ConclusionsThe ROSE AI system demonstrated feasibility and robustness in identifying specimen adequacy, showing potential enhancement in the diagnostic yield of FB. Nevertheless, additional enhancements, incorporating a more diverse range of training data and leveraging advanced AI models with increased capabilities, along with rigorous validation through extensive multi-center randomized control assays, are crucial to guarantee the seamless and effective integration of this technology into clinical practice.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Bronchoscopy | Cancer | Cancer & Oncology | Carcinoma | Cytology | Learning | Lung Cancer | Lung Transplant | Skin Cancer | Squamous Cell Carcinoma | Training | Universities & Medical Training